Becton Dickinson and Company Limited

C. R. Bard, Inc.

Eric Fallows

Robert L Campbell

Kevin G Dolan

J Bruce Pitner

Glenn P Vonk

Randal A Hoke

Ross Jacobson

Dwight Livingston

Melody M H Kuroda

Adam C Curry

Kristin Weidemaier

Mark A Talmer

Thomas D Haubert

Jack H Kessler

Ammon David Lentz

Michael A Brasch

James A Prescott

Richard L Moore

Alexander George Lastovich

Artis R Lockhart

Michael L Marshall

Gregory S Kramer

Michael Justin Lizzi

William Kevin Carpenter

Scott Nicholas Danhof

M Scott Ulrich

Nicholas J Jardine

Owen Lewis Joyce

Joshua Herr

Rosemary B Evans-Storms

Rajashaker Kache

Ernie Ritchey

Andrea Liebmann-Vinson

Qihua Xu

Randy J Somerville

David S Sebba

Donald E Gorelick

Richard Abbot

Jack Kessler

Spencer Lovette

Miroslaw Bartkowiak

Jon E Salomon

Jill Walthall Jones

Herman D Himel, Iv

Erin Gooch Carruthers

Scott N Danhof

Wendy Dale Woodley

Cristian Clavijo

Kuilin Lai

Alexander Adam Papp

Upma Gulati

Sean E Walker

Herman Himel

Adam T Martin

Shirley Ng

Abigail A Wilms

Jeffrey S Ojala

Sean Connell

Melody Mh Kuroda

David S Sebra

Meghan Wolfgang

Disclosed herein is a system for monitoring urine output (UO) of a patient. The system includes a UO module configured to couple with a collection container. The UO module includes (i) a frame configured for anchoring to frame rails of a bed, (ii) a load cell configured to measure a weight of UO within the container and (iii) logic stored in memory that determines volumetric UO data from the load cell and transmits the UO data across a network to an external entity. An intermediate coupling device between the collection container and the UO module is configured to couple with the collection container and inhibit decoupling from the collection container. The intermediate coupling device includes an identification device attached thereto, identification device including patient information, and the logic links the UO data to the patient information.

Automated urine output system for attachment to hospital bed

A medical pad for exchanging thermal energy between a targeted temperature management (TTM) fluid and a patient is disclosed. The pad can include a fluid containing layer and a fluid conduit attached therewith via rotatable joint where the joint is configured to facilitate rotation of the fluid conduit with respect to the pad. A method of manufacturing the pad can include coupling a first member of the rotatable joint to a fluid delivery line, coupling the second member to the fluid containing layer, and inserting the first member within an opening of the second member to facilitate a snap-fit retention mechanism between first member and the second member. A method of using the pad can include rotating the fluid delivery line relative to the thermal pad via the rotatable joint when initially applying the pad to the patient or when adjusting an orientation of the pad on the patient.

Gel pad assembly using free rotatable fluid joints

Some embodiments provided herein relate to combined assays. In some embodiments, an assay for identifying influenza type A or influenza type B is combined with an assay for determining the sensitivity of an influenza neuraminidase to an antiviral drug.

Methods and kits for the diagnosis of influenza

Disclosed herein is an automated urinary output monitoring system including urine collection assembly that includes a first drainage tube coupled between a urinary catheter and an interim container, and a second drainage coupled between the interim container and a final container. A scale measures the weight of urine collected in the final container and a display depicts the volume of urine collected in the final container. A vacuum pump can be coupled with the final container to draw urine from the interim container into the final container, and an air vent can isolate the patient from the vacuum within the final container. The system can be configured to wirelessly transmit urine volume data to an external computing device. A gyroscope can be coupled with the scale to determine the orientation of the scale. Logic of the system can calculate urine volume and correlate with the time of day.

Automated urinary output monitoring system

Provided herein are methods, systems, and devices for detecting and/or identifying one or more specific microorganisms in a culture sample. Indicator particles, such as surface enhanced Raman spectroscopy (SERS)-active nanoparticles, each having associated therewith one or more specific binding members having an affinity for the one or more microorganisms of interest, can form a complex with specific microorganisms in the culture sample. Further, agitating magnetic capture particles also having associated therewith one or more specific binding members having an affinity for the one or more microorganisms of interest can be used to capture the microorganism-indicator particle complex and concentrate the complex in a localized area of an assay vessel for subsequent detection and identification. The complex can be dispersed, pelleted, and redispersed so that the culture sample can be retested a number of times during incubation so as to allow for real-time monitoring of the culture sample.

Methods, systems, and devices for detecting and identifying microorganisms in microbiological culture samples

Method and kits for the diagnosis of influenza

Growing community of inventors

Apex, NC, United States of America

Eric Fallows